IN2013CN00536A - - Google Patents
Info
- Publication number
- IN2013CN00536A IN2013CN00536A IN536CHN2013A IN2013CN00536A IN 2013CN00536 A IN2013CN00536 A IN 2013CN00536A IN 536CHN2013 A IN536CHN2013 A IN 536CHN2013A IN 2013CN00536 A IN2013CN00536 A IN 2013CN00536A
- Authority
- IN
- India
- Prior art keywords
- protein
- hpv52
- truncated
- vlp
- infection
- Prior art date
Links
- 108700042300 human papillomavirus type 52 L1 Proteins 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 241000701806 Human papillomavirus Species 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 1
- 108091026890 Coding region Proteins 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 201000010881 cervical cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/892—Reproductive system [uterus, ovaries, cervix, testes]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010216189 | 2010-07-02 | ||
| PCT/CN2011/076763 WO2012000454A1 (zh) | 2010-07-02 | 2011-07-01 | 截短的人乳头瘤病毒52型l1蛋白 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013CN00536A true IN2013CN00536A (enrdf_load_stackoverflow) | 2015-07-03 |
Family
ID=45050553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN536CHN2013 IN2013CN00536A (enrdf_load_stackoverflow) | 2010-07-02 | 2011-07-01 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9499591B2 (enrdf_load_stackoverflow) |
| EP (1) | EP2589604B1 (enrdf_load_stackoverflow) |
| CN (1) | CN102268076B (enrdf_load_stackoverflow) |
| DK (1) | DK2589604T3 (enrdf_load_stackoverflow) |
| IN (1) | IN2013CN00536A (enrdf_load_stackoverflow) |
| WO (1) | WO2012000454A1 (enrdf_load_stackoverflow) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103044531B (zh) * | 2012-09-29 | 2014-07-30 | 重庆原伦生物科技有限公司 | 耐甲氧西林金黄色葡萄球菌(mrsa)疫苗重组蛋白抗原hi2的纯化方法 |
| CN106701796B (zh) * | 2015-08-12 | 2021-11-16 | 北京康乐卫士生物技术股份有限公司 | 52型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
| CN105985934A (zh) * | 2015-08-18 | 2016-10-05 | 北京康乐卫士生物技术股份有限公司 | 一种二价、三价或多价hpv假病毒及其应用 |
| CN106831959B (zh) * | 2015-12-04 | 2019-11-05 | 厦门大学 | 一种人乳头瘤病毒33型l1蛋白的突变体 |
| US10940194B2 (en) | 2015-12-04 | 2021-03-09 | Xiamen University | Mutant of L1 protein of human papillomavirus type 58 |
| CN107557347B (zh) * | 2016-06-30 | 2022-03-29 | 中国科学院上海巴斯德研究所 | 肠道病毒71型的新型病毒样颗粒、其制备方法及应用 |
| CN114174319B (zh) * | 2019-07-19 | 2024-05-14 | 神州细胞工程有限公司 | 嵌合的人乳头瘤病毒52型l1蛋白 |
| MX2022000777A (es) * | 2019-07-19 | 2022-02-14 | Sinocelltech Ltd | Composicion de inmunogenicidad polivalente para el virus de papiloma humano. |
| CN114539365B (zh) * | 2020-11-26 | 2023-12-01 | 中国医学科学院基础医学研究所 | 一种改造的人乳头瘤病毒52型l1蛋白及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3730600A (en) * | 1999-03-18 | 2000-10-04 | Xiaojiang Chen | Compositions preparations and uses of human papillomavirus l1 protein |
| CN1293093C (zh) | 2002-08-30 | 2007-01-03 | 马润林 | 乳头瘤病毒衣壳蛋白的原核制备和应用 |
| BRPI0509079B8 (pt) * | 2004-03-24 | 2021-07-06 | Merck & Co Inc | molécula de ácido nucléico, vetor, célula hospedeira, partículas tipo vírus, método para produzir vlps, vacina, composições farmacêuticas, e, métodos para evitar infecção por hpv e para induzir uma resposta imune em um animal |
| CN101153280B (zh) | 2006-09-29 | 2015-08-19 | 厦门大学 | 从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法 |
| CN101293918B (zh) * | 2007-04-29 | 2013-03-27 | 北京万泰生物药业股份有限公司 | 截短的人乳头瘤病毒16型l1蛋白 |
| US9364529B2 (en) * | 2007-04-29 | 2016-06-14 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | Truncated L1 protein of human papillomavirus type 18 |
| BRPI0810951B8 (pt) * | 2007-05-29 | 2021-05-25 | Beijing Wantai Biological Pharmacy Entpr Co Ltd | proteína l1 do hpv6, polinucleotídeo, vetor, célula, partícula semelhante ao vírus (vlp) hpv6, método para produzir a proteína hpv6 l1 truncada, vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína hpv6 l1 truncada, método para prevenção de condiloma acuminado ou infecções por hpv, método para obter uma vlp de uma proteína l1 do hpv6 e método para produzir uma vacina para a prevenção de condiloma acuminado ou de infecções por hpv |
| US9533035B2 (en) * | 2007-05-29 | 2017-01-03 | Xiamen University | Truncated L1 protein of human papillomavirus type 11 |
-
2011
- 2011-07-01 IN IN536CHN2013 patent/IN2013CN00536A/en unknown
- 2011-07-01 US US13/807,858 patent/US9499591B2/en active Active
- 2011-07-01 DK DK11800199.9T patent/DK2589604T3/en active
- 2011-07-01 CN CN201110182799.7A patent/CN102268076B/zh active Active
- 2011-07-01 WO PCT/CN2011/076763 patent/WO2012000454A1/zh active Application Filing
- 2011-07-01 EP EP11800199.9A patent/EP2589604B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9499591B2 (en) | 2016-11-22 |
| CN102268076B (zh) | 2017-04-26 |
| DK2589604T3 (en) | 2017-01-16 |
| EP2589604A4 (en) | 2013-12-18 |
| WO2012000454A1 (zh) | 2012-01-05 |
| US20130230548A1 (en) | 2013-09-05 |
| EP2589604B1 (en) | 2016-10-05 |
| EP2589604A1 (en) | 2013-05-08 |
| CN102268076A (zh) | 2011-12-07 |
| BR112013000031A2 (pt) | 2016-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2013CN00536A (enrdf_load_stackoverflow) | ||
| EA201190327A1 (ru) | Новые конструкции белка вируса папилломы человека (hpv) и их применение в предупреждении заболевания, вызываемого hpv | |
| TR201908199T4 (tr) | HPV'ye karşı aşılar. | |
| CA2817005A1 (en) | Rabies glycoprotein virus-like particles (vlps) | |
| MX2011007692A (es) | Vacunas mejoradas para el virus del papiloma humano y procedimientos para su utilizacion. | |
| BR112015021974A2 (pt) | Composição, e, método de indução de uma resposta imune | |
| MX379069B (es) | Vacunas terapeuticas contra el vph16. | |
| WO2007095320A3 (en) | Hpv antigens, vaccine compositions, and related methods | |
| IN2014DN03054A (enrdf_load_stackoverflow) | ||
| MX2011007307A (es) | Vector de expresion estable contitutivamente alto para preparar vacuna vph y bacteria acido lactica recombinante transformada del mismo modo. | |
| WO2008034388A8 (fr) | Particules virales de protéines de la capside provenant du papillomavirus humain de type 16/58/18/6/11 et leur procédé de préparation et leurs utilisations | |
| NZ702146A (en) | Peptides derived from viral proteins for use as immunogens and dosage reactants | |
| PH12014501388A1 (en) | A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv | |
| ZA202100386B (en) | Influenza virus hemagglutinin mutants | |
| PH12022553102A1 (en) | Vaccines for recurrent respiratory papillomatosis and methods of using the same | |
| EA033242B1 (ru) | Усовершенствованные нуклеиновые кислоты и белки вируса человеческой папилломы, вакцины и композиции на их основе и способы индукции иммунного ответа против впч с их применением | |
| WO2008082719A3 (en) | Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors | |
| NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella | |
| UA98254C2 (ru) | мукозальная вакцина для иммунотерапии заболеваний, обусловленных вирусами папилломы человека | |
| AR077398A2 (es) | Particulas similares a virus de hpv31 (virus del papiloma humano). metodo para producirlas, vacuna y composicion que las contienen | |
| EA200702077A1 (ru) | Вакцина | |
| WO2010147971A3 (en) | Il23 modified viral vector for recombinant vaccines and tumor treatment | |
| WO2019113285A3 (en) | Zika vaccines and methods of use | |
| SE0002498D0 (sv) | Papillomavirus vaccine | |
| EA201700162A1 (ru) | Оптимизированный гибридный белок вируса папилломы человека для использования в качестве антигена в терапевтической вакцине |